Growing Role as Biologically Important Organic Compounds in Drug Development to Drive Growth in the Global D-Amino Acids Market

Rising significance of D-amino acids in pharmaceutical drug development and manufacturing applications is poised to drive the global D-Amino Acids market to reach US$236.4 million by 2024.

Amino acids, the building blocks of human body, occur in two sterioisomeric forms, namely L-amino acids and D-amino acids. L-forms of amino acids are associated with making up proteins in the human body, whereas D-forms of amino acids are very rare. D-amino acids meanwhile are regarded as essential intermediates to produce various chemicals, agrochemicals, pharmaceuticals and food & feed additives. D-amino acids are found in bacterial proteoglycan cell walls and in several peptide antibiotics and can address specific demands of human body as compared to L-amino acids. Global market for D-amino acids market is witnessing growth supported by the expanding range of applications. The increased R&D focus on developing simple production processes is expected to lead to expanded range of applications for D-amino acids in the coming years. While pharmaceutical sector remains the mainstay for D-amino acids market, the growing demand for animal feed and processed foods will also present growth opportunities in the coming years. In the pharmaceutical sector,

D-amino acids are mainly utilized in the production of synthetic peptides as well as peptide-based drugs. Since D-amino acid-based peptides are known to possess synthetizing characteristics, they find use in the treatment of conditions such as tumors and Alzheimer’s disease. In addition, D-amino based peptides find use in synthetic peptide protease inhibitors in keratotomy as well as in synthetic peptide anti-pain analgesics. As a result of the increasing production of peptides for pharmaceutical applications is expected to propel demand for D-amino acids in the pharmaceutical industry. D-amino acids are also utilized for synthesizing anti-epilepsy drugs, nicotinamide acetylcholine receptors, calcium channels, endorphin releasing drugs, and sodium channels. The continuous increase in prevalence of various chronic diseases and the subsequent need for timely diagnosis and treatment of such diseases is thus expected to drive demand for D-amino acids in the upcoming years.

D-amino acids are also known to play a vital role in critical human body processes such as energy production, nutrient absorption, tissue growth and immune function. D-amino acids are also known to play a role in improving performance of athletes, alleviating fatigue, promoting recovery of muscles, and promoting weight loss. Driven by the rising awareness about the health advantages of D-amino acids, the market for D-amino acids is likely to gain momentum in the coming years. On the other hand, in the food & beverage industry, peptides that contain D-amino acids are utilized in the form of sweeteners. In the cosmetics industry, D-amino acids are used as therapeutic agents for atopic dermatitis, wrinkle formation inhibitors and skin moisturizers.

As stated by the new market research report on D-Amino Acids, Asia-Pacific represents the largest regional market, worldwide. Asia-Pacific’s large share in the global D-amino acids market is mainly attributed to the region being a major manufacturing location for the pharmaceutical industry, the largest end-use market for D-amino acids. Driven by the rapid growth of the pharmaceutical manufacturing activity in the region, Asia-Pacific is forecast to grow at the fastest CAGR of 6.8% over the analysis period. The growing health needs of expanding geriatric population, vast patient pool and increasing access to healthcare services are leading to increased demand for D-amino acids in pharmaceutical manufacturing activities. Low operating costs, availability of low cost and skilled workforce and the vast customer base have been driving a number of western pharmaceutical companies to outsource their manufacturing activities to Asian countries, thus driving demand for D-amino acids. In addition, increased focus on R&D initiatives for expanding use of D-amino acids into new applications and industries will also present significant growth opportunities for Asia-Pacific in the years ahead.

Major players in the market include Adisseo France S.A.S, Ajinomoto Co. Inc., AnaSpec Inc., Evonik Industries AG, IRIS Biotech GmbH, LifeSpan Biosciences Inc., Merck KGaA, Sekisui Medical Co. Ltd., Shanghai Hanhong Chemical Co. Ltd., Sichuan Tongsheng Amino acid Co. Ltd., Sumitomo Chemical Company Limited, TCI America Inc., Tocris Bioscience, and Zhangjiagang Huachang Pharmaceutical Co. Ltd.

The research report titled “D-Amino Acids – Market Analysis, Trends, and Forecasts” announced by Global Industry Analysts Inc., provides a comprehensive review of market trends, issues, drivers, mergers, acquisitions and other strategic industry activities of global companies. The report provides market estimates and projections for all major geographic markets such as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and Rest of Europe), Asia-Pacific (China and Rest of Asia-Pacific), Middle East & Africa, and Latin America. The D-Amino Acids market is analyzed by the following End-Use Applications – Industrial, Pharmaceutical and Others.

For enquiries e-mail us at rsd@strategyr.com or info411@strategyr.com.

For cutting edge analyst reviews on top industries

Follow us on Twitter; Connect with us on LinkedIn; Follow us on Medium